Want to track HNSA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Hansa Biopharma AB (publ) (HNSA) Statistics
Valuation metrics
Market Cap 2.08B
Enterprise value 4.54B
Trailing P/E (ttm) -5.18
Forward P/E -
PEG ratio 1.99
Price/Sales (ttm) 21.44
Price/Book (mrq) -7.97
Enterprise Value/Revenue 23.97
Enterprise Value/EBITDA -7.98
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1M
Average volume (90 days) 582.19K
Price summary
52-Week low 22.82
52-Week high 42.98
Beta -
50-Day moving average 34.51
200-Day moving average 32.59
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 816:775
Last split Date 16 Mar 2015
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -4.06%
Operating margin -3.11%
Operational effectiveness
Return on assets -0.72%
Return on equity 2.13%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 1.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -7.57
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.43
Total debt (mrq) -
Total Debt/Equity (mrq) -1.99
Current ratio (mrq) 1.25%
Book value per share (mrq) -5.11
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
